FAP-1 in pancreatic cancer cells: Functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis

Journal of Cell Science

Volumn 114, Issue 15, 2001, Pages 2735-2746

  Ungefroren, H ^a   Kruse, M L ^a   Trauzold, A ^a   Roeschmann, S ^a   Roeder, C ^a   Arlt, A ^a   Henne Burns, D ^a   Kalthoff, H ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

CD95 induced cell death; Human; Immune escape; Pancreatic cancer

Indexed keywords

BREFELDIN A; CASPASE 3; COMPLEMENTARY DNA; DNA FRAGMENT; FAS ANTIGEN; FAS ASSOCIATED PHOSPHATASE 1; ORTHOVANADIC ACID; PROTEIN TYROSINE PHOSPHATASE; SYNTHETIC PEPTIDE; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL PROTECTION; CELL SURFACE; CELL TRANSPORT; CELL VACUOLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOPLASM; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE ACTIVATED CELL SORTER; GENETIC TRANSFECTION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MICROINJECTION; PANCREAS CANCER; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; STAINING; TUMOR CELL;

ADENOCARCINOMA; ANTIGENS, CD95; APOPTOSIS; BREFELDIN A; CARRIER PROTEINS; CYTOPLASMIC VESICLES; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GOLGI APPARATUS; HUMANS; JURKAT CELLS; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 0034858398     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients
2. A novel protein-tyrosine phosphatase with homology to both the cytoskeletal proteins of the band 4.1 family and the junction-associated guanylate kinases
3. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
4. Brefeldin A: The advantage of being uncompetitive
5. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis
6. β-COP, a 110 kD protein associated with non-clathrin-coated vesicles and the Golgi complex, shows homology to β-adaptin
7. NF-kappaB regulates Fas/APO-1/CD95- and TCR-mediated apoptosis of T lymphocytes
8. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis
9. Constitutive CD95 ligand expression in several non-lymphoid mouse tissues: Implications for immune-protection and cell turnover
10. Fas-mediated apoptosis in seven human prostate cancer cell lines: Correlation with tumor stage
11. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis
12. The Fas signaling pathway is functional in colon carcinoma cells and induces apoptosis
13. PTPN13, a Fas-associated protein tyrosine phosphatase, is located on the long arm of chromosome 4 at band q21.3
14. Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75(NTR) and their effect on NF-kappaB activation
15. Inhibition of death receptor signals by cellular FLIP
16. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines
17. CD95(APO-1/Fas)-mediated apoptosis: Live and let die
18. CD95(APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells
19. In vivo expression of soluble Fas and FAP-1: Possible mechanisms of Fas resistance in human hepatoblastomas
20. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
21. Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells
22. Molecular cloning of a novel protein-tyrosine phosphatase containing a membrane-binding domain and GLGF repeats
23. Association of protein-tyrosine phosphatase PTP-BAS with the transcription-factor-inhibitory protein IkappaBalpha through interaction between the PDZ1 domain and ankyrin repeats
24. The JAM test: A simple assay for DNA fragmentation and cell death
25. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers
26. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis
27. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows
28. Apoptosis by death factor
29. Resistance to Fas-mediated apoptosis in human hepatoma cells
30. Protection against CD95/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin
31. CD95 (APO-1/Fas)-associating signalling proteins
32. Double identity for proteins of the Bcl-2 family
33. Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins
34. Characterization of the interactions between PDZ domains of the protein-tyrosine phosphatase PTPL1 and the carboxyl-terminal tail of Fas
35. FAP-1: A protein tyrosine phosphatase that associates with Fas
36. Role for tyrosine phosphorylation and Lyn tyrosine kinase in fas receptor-mediated apoptosis in eosinophils
37. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas
38. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
39. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand
40. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis
41. Cell death induction by TNF: A matter of self control
42. The molecular interaction of Fas and FAP-1
43. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis
44. Down-regulation of fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells
45. Rel blocks both anti-Fas- and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect